193 related articles for article (PubMed ID: 10454586)
1. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
3. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
[TBL] [Abstract][Full Text] [Related]
4. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
Wang D; Russell JL; Johnson DG
Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
[TBL] [Abstract][Full Text] [Related]
5. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
7. The paradox of E2F1: oncogene and tumor suppressor gene.
Johnson DG
Mol Carcinog; 2000 Mar; 27(3):151-7. PubMed ID: 10708476
[TBL] [Abstract][Full Text] [Related]
8. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
9. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
[TBL] [Abstract][Full Text] [Related]
10. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
11. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic capacity of the E2F1 gene.
Johnson DG; Cress WD; Jakoi L; Nevins JR
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12823-7. PubMed ID: 7809128
[TBL] [Abstract][Full Text] [Related]
13. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J
Cell Growth Differ; 1999 Dec; 10(12):829-38. PubMed ID: 10616908
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
15. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
Wang D; Russell J; Xu H; Johnson DG
Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
[TBL] [Abstract][Full Text] [Related]
16. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
Dimri GP; Itahana K; Acosta M; Campisi J
Mol Cell Biol; 2000 Jan; 20(1):273-85. PubMed ID: 10594030
[TBL] [Abstract][Full Text] [Related]
17. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
[TBL] [Abstract][Full Text] [Related]
18. A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription.
Gartel AL; Najmabadi F; Goufman E; Tyner AL
Oncogene; 2000 Feb; 19(7):961-4. PubMed ID: 10702805
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of E2F transcription factors in chemically induced mouse skin tumors.
Balasubramanian S; Ahmad N; Mukhtar H
Int J Oncol; 1999 Aug; 15(2):387-90. PubMed ID: 10402252
[TBL] [Abstract][Full Text] [Related]
20. Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
Reinke V; Bortner DM; Amelse LL; Lundgren K; Rosenberg MP; Finlay CA; Lozano G
Cell Growth Differ; 1999 Mar; 10(3):147-54. PubMed ID: 10099828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
